| Trial registration number
|
NCT05313074 |
Full text link
Last imported at : April 7, 2022, 9:30 p.m.
Source : ClinicalTrials.gov
|
https://clinicaltrials.gov/show/NCT05313074
|
First author
Last imported at : April 7, 2022, 9:30 p.m.
Source : ClinicalTrials.gov
|
Thanarath Imsuwansri
|
Contact
Last imported at : April 7, 2022, 9:30 p.m.
Source : ClinicalTrials.gov
|
Not reported
|
Registration date
Last imported at : April 7, 2022, 9:30 p.m.
Source : ClinicalTrials.gov
|
2022-04-06
|
Recruitment status
Last imported at : April 7, 2022, 9:30 p.m.
Source : ClinicalTrials.gov
|
Completed
|
Study design
Last imported at : April 7, 2022, 9:30 p.m.
Source : ClinicalTrials.gov
|
nonRCT
|
Allocation
Last imported at : April 7, 2022, 9:30 p.m.
Source : ClinicalTrials.gov
|
Non-randomized
|
Design
Last imported at : April 7, 2022, 9:30 p.m.
Source : ClinicalTrials.gov
|
Parallel
|
Masking
Last imported at : April 7, 2022, 9:30 p.m.
Source : ClinicalTrials.gov
|
Open label
|
Center
Last imported at : March 15, 2023, 4 a.m.
Source : ClinicalTrials.gov
|
single-center
|
Study aim
Last imported at : April 7, 2022, 9:30 p.m.
Source : ClinicalTrials.gov
|
Prevention
|
Inclusion criteria
Last imported at : April 19, 2022, midnight
Source : ClinicalTrials.gov
|
inclusion criteria:
male or female age at least 18 years
patients with a diagnosis of solid tumors
ability to understand the patient information and study consent. signed and dated written informed consent must be available before performing any study-related procedure
willing and able to comply with the study procedures.
willing to receive a coronavac vaccine (sinovac).
|
Exclusion criteria
Last imported at : April 19, 2022, midnight
Source : ClinicalTrials.gov
|
patients who cannot provide consent
|
Number of arms
Last imported at : April 7, 2022, 9:30 p.m.
Source : ClinicalTrials.gov
|
2
|
Funding
Last imported at : April 7, 2022, 9:30 p.m.
Source : ClinicalTrials.gov
|
National Cancer Institute, Thailand
|
Inclusion age min
Last imported at : April 7, 2022, 9:30 p.m.
Source : ClinicalTrials.gov
|
18
|
Inclusion age max
Last imported at : April 7, 2022, 9:30 p.m.
Source : ClinicalTrials.gov
|
100
|
Countries
Last imported at : April 7, 2022, 9:30 p.m.
Source : ClinicalTrials.gov
|
Thailand
|
Type of patients
Last imported at : April 7, 2022, 9:30 p.m.
Source : ClinicalTrials.gov
|
Healthy volunteers
|
Severity scale
Last imported at : April 7, 2022, 9:30 p.m.
Source : ClinicalTrials.gov
|
N/A
|
Total sample size
Last imported at : April 7, 2022, 9:30 p.m.
Source : ClinicalTrials.gov
|
311
|
primary outcome
Last imported at : April 19, 2022, midnight
Source : ClinicalTrials.gov
|
Immune response of Coronavac vaccine in Thai cancer patients
|
Notes
Last imported at : April 7, 2022, 9:30 p.m.
Source : ClinicalTrials.gov
|
None
|
Phase
Last imported at : April 7, 2022, 9:30 p.m.
Source : ClinicalTrials.gov
|
Not reported
|
Arms
Last imported at : April 7, 2022, 9:30 p.m.
Source : ClinicalTrials.gov
|
[{"arm_notes": "Cancer patients", "treatment_id": 327, "treatment_name": "Coronavac", "treatment_type": "Inactivated virus", "pharmacological_treatment": "Vaccine"}, {"arm_notes": "Healthy volunteers", "treatment_id": 327, "treatment_name": "Coronavac", "treatment_type": "Inactivated virus", "pharmacological_treatment": "Vaccine"}]
|